Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease

…, K Tamura, T Tomomasa, T Kobayashi, A Morikawa - Circulation, 2006 - Am Heart Assoc
Background— In the present study, we developed models to predict unresponsiveness to
intravenous immunoglobulin (IVIG) in Kawasaki disease (KD). Methods and Results— We …

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label …

…, H Tokunaga, S Takatsuki, S Hara, A Morikawa - The Lancet, 2012 - thelancet.com
Background Evidence indicates that corticosteroid therapy might be beneficial for the primary
treatment of severe Kawasaki disease. We assessed whether addition of prednisolone to …

A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome

…, T Tomomasa, K Takeuchi, A Morikawa… - The Journal of …, 2006 - Elsevier
OBJECTIVE: To investigate the role of corticosteroids in the initial treatment of Kawasaki
disease (KD). STUDY DESIGN: Between September 2000 and March 2005, we randomly …

Effects of SO2 on Respiratory System of Adult Miyakejima Resident 2 Years after Returning to the Island

…, T Takebayashi, M Adachi, A Morikawa… - Journal of …, 2009 - Wiley Online Library
Effects of SO 2 on Respiratory System of Adult Miyakejima Resident 2 Years after Returning
to the Island: Satoko Iwasawa, et al. Department of Preventive Medicine and Public Health, …

Relationship between concentration of serum leptin and fetal growth

…, K Nagashima, Y Nako, A Morikawa - The Journal of Clinical …, 1997 - academic.oup.com
The serum leptin concentration reflects the amount of adipose tissue in the body. Although
fat deposition in the fetus in the third trimester markedly increases, the role of leptin during …

Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children

…, Y Inoue, T Tomomasa, T Kobayashi, A Morikawa - The Journal of …, 2003 - Elsevier
OBJECTIVE: The aim of this multicenter prospective and randomized study was to determine
the effect of adding corticosteroids to intravenous gamma globulin (IVGG) therapy on serum …

Corticosteroids in the treatment of the acute phase of Kawasaki disease

M Shinohara, K Sone, T Tomomasa, A Morikawa - The Journal of pediatrics, 1999 - Elsevier
Objectives: Corticosteroids are considered to be contraindicated during the acute phase of
Kawasaki disease (KD) based on unfavorable results in early studies. In our hospital, however…

Childhood cough variant asthma and its relationship to classic asthma

…, H Mochizuki, K Tokuyama, A Morikawa - Annals of Allergy, Asthma …, 2003 - Elsevier
BACKGROUND: In pediatrics, some patients with chronic cough who have no evidence of a
causative disease are diagnosed as having cough variant asthma (CVA). The precise …

Japanese guidelines for childhood asthma 2017

…, S Nishima, T Nishimuta, A Morikawa… - Allergology …, 2017 - jstage.jst.go.jp
The Japanese Guideline for the Diagnosis and Treatment of Allergic Diseases 2017 (JAGL
2017) includes a minor revision of the Japanese Pediatric Guideline for the Treatment and …

Serum procalcitonin concentration in patients with Kawasaki disease

…, M Kato, Y Inoue, K Kozawa, H Kimura, A Morikawa - Journal of infection, 2004 - Elsevier
Background. Procalcitonin (PCT) is a new parameter of inflammation, the clinical usefulness
of which is currently being evaluated. Materials and methods. We determined …